
Akumin AKU
Quarterly report 2023-Q3
added 12-12-2023
Akumin P/CF Ratio 2011-2026 | AKU
Annual P/CF Ratio Akumin
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.15 | 4.87 | 16.7 | - | -77.1 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16.7 | -77.1 | -13.6 |
P/CF Ratio of other stocks in the Diagnostics research industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M | ||
|
Agilent Technologies
A
|
28.3 | $ 119.13 | -0.53 % | $ 36.2 B | ||
|
Burning Rock Biotech Limited
BNR
|
-40.2 | $ 19.95 | -2.97 % | $ 215 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 21.75 | 23.79 % | $ 1.16 B | ||
|
Medpace Holdings
MEDP
|
18.2 | $ 522.17 | 0.7 % | $ 15.1 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
NeoGenomics
NEO
|
284 | $ 8.41 | -3.05 % | $ 1.08 B | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 9.25 | -1.8 % | $ 2.01 B | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Koninklijke Philips N.V.
PHG
|
26.5 | $ 29.01 | -0.28 % | $ 20 B | ||
|
Co-Diagnostics
CODX
|
-0.201 | $ 1.39 | -2.11 % | $ 1.85 M | ||
|
Castle Biosciences
CSTL
|
10.9 | $ 24.56 | -0.24 % | $ 682 M | ||
|
Senseonics Holdings
SENS
|
-5.93 | $ 6.81 | -1.38 % | $ 284 M | ||
|
Soleno Therapeutics
SLNO
|
44.5 | $ 52.62 | 0.09 % | $ 2.67 B | ||
|
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.63 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
Neuronetics
STIM
|
-3.98 | $ 1.37 | -1.44 % | $ 90.4 M | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 181.93 | 0.76 % | $ 9.02 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
Danaher Corporation
DHR
|
23.3 | $ 194.68 | -1.75 % | $ 139 B | ||
|
Interpace Biosciences
IDXG
|
1.26 | $ 2.15 | -2.45 % | $ 9.51 M | ||
|
Thermo Fisher Scientific
TMO
|
25.1 | $ 522.98 | -1.63 % | $ 197 B | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
Trinity Biotech plc
TRIB
|
9.03 | $ 0.7 | -0.28 % | $ 61.9 M | ||
|
Illumina
ILMN
|
19.6 | $ 131.27 | -0.75 % | $ 20.9 B | ||
|
Twist Bioscience Corporation
TWST
|
-32.8 | $ 56.88 | -1.29 % | $ 3.4 B | ||
|
Fulgent Genetics
FLGT
|
22.2 | $ 16.17 | - | $ 489 M | ||
|
Guardant Health
GH
|
-72.7 | $ 86.41 | 1.83 % | $ 10.8 B | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
-0.0144 | $ 2.84 | -3.07 % | $ 92.2 K | ||
|
Biomerica
BMRA
|
-1.87 | $ 2.17 | 2.84 % | $ 4.98 M | ||
|
ICON Public Limited Company
ICLR
|
12.9 | $ 117.4 | 0.77 % | $ 9.68 B | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 268.93 | 0.82 % | $ 22.4 B | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
Celcuity
CELC
|
-35 | $ 124.87 | 1.13 % | $ 5.84 B | ||
|
Waters Corporation
WAT
|
30.1 | $ 323.42 | -0.85 % | $ 19.3 B | ||
|
Myriad Genetics
MYGN
|
227 | $ 5.17 | -0.39 % | $ 479 M | ||
|
Lantheus Holdings
LNTH
|
13.1 | $ 83.34 | -0.72 % | $ 5.62 B | ||
|
Quest Diagnostics Incorporated
DGX
|
12.4 | $ 194.05 | 1.37 % | $ 21.5 B |